Circulating immune complexes induced by food proteins implicated in precocious myocardial infarction

References

• Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 342: 115–26
   Google Scholar
• Mannik M, Arend WP, Hall AP, Gilliland BC. Studies on antigen-antibody complexes I. Elimination of soluble complexes from rabbit circulation. J Exp Med 1971; 133: 713–39
   PubMed Web of Science ®Google Scholar
• Qiao JH, Castellani LW, Fishbein MC, Lusis AJ. Immune complex mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice. Arterioscler Thromb 1993; 13: 932–43
   PubMedGoogle Scholar
• Wissler RW, Vesselinovitch D, Ko C. The effects of circulating immune complexes on atherosclerotic lesions in experimental animals and in younger and older humans. Transplant Proc 1989; 21: 3707–8
   PubMedGoogle Scholar
• Meller J, Conde CA, Deppisch LM, Donoso E, Dack S. Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus. Am J Cardiol 1975; 35: 309–14
   PubMedGoogle Scholar
• Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jr, Jansen-McWilliamsn L. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408–15
   PubMed Web of Science ®Google Scholar
• Erhardt CC, Mumford PA, Venables PJ, Maini RN. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis 1989; 48: 7–13
   PubMed Web of Science ®Google Scholar
• Bely M, Apathy A, Beke-Martos E. Cardiac changes in rheumatoid arthritis. Acta Morphol Hung 1992; 40: 149–86
   PubMedGoogle Scholar
• Farrell C, Bloth B, Nielsen H, Dougharty H, Lundman T, Svehag SE. A survey for circulating immune complexes in patients with acute myocardial infarction. Use of a C1q-binding assay with soluble protein A as indicator. Scand J Immunol 1977; 6: 1233–40
   PubMed Web of Science ®Google Scholar
• Szondy E, Zsuzsa M, Fust G, Szekely J, Gero S. Serial measurement of circulating immune complexes in myocardial infarction. Br Heart J 1981; 46: 93–8
   PubMedGoogle Scholar
• Steffen C, Bohm H, Menzel J. Immune complexes in myocardial infarction. Wien Klin Wochenschr 1986; 98: 161–5
   PubMedGoogle Scholar
• Lefvert AK, Hamsten A, Holm G. Association between circulating immune complexes, complement C4 null alleles, and myocardial infarction before the age of 45 years. Arterioscler Throm Vase Biol 1995; 15: 665–8
   PubMedGoogle Scholar
• Linnanmäki E, Leinonen M, Manila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130–4
   PubMed Web of Science ®Google Scholar
• Leinonen M, Linnanmäki E, Manila K, Nieminen MS, Valtonen V, Leirisalo-Repo M. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog 1990; 9: 67–73
   PubMed Web of Science ®Google Scholar
• Nityanand S, Holm G, Lefvert AK. Immune complex mediated vasculitis in hepatitis B and C infections and the effect of antiviral therapy. Clin Immunol Immunopathol 1997; 82: 250–7
   PubMedGoogle Scholar
• Annand JC. Hypothesis: heated milk protein and thrombosis. J Atherosclerosis Res 1967; 7: 797–800
   Google Scholar
• Davies DF, Johnson AP, Rees BWG, Elwood PC, Abernethy M. Food antibodies and myocardial infarction. Lancet 1974; I: 1012–14
   Google Scholar
• Muscari A, Volta U, Bonazzi C, Puddu GM, Bozzoli C, Gerratana C. Association of serum IgA antibodies to milk antigens with severe atherosclerosis. Atherosclerosis 1989; 77: 251–6
   PubMedGoogle Scholar
• Toivanen A, Viljanen MK, Savilahti E. IgM and IgG anti-milk antibodies measured by radioimmunoassay in myocardial infarction. Lancet 1975; ii: 205–7
   Google Scholar
• Gibney MJ, Gallagher PJ, Sharratt GP, Benning HS, Taylor G, Pitts JM. Antibodies to heated milk protein in coronary heart disease. Atherosclerosis 1980; 37: 151–5
   PubMedGoogle Scholar
• Giscombe R, Grunewald J, Nityanand S, Lefvert AK. TCR V gene usage in patients with systemic necrotizing vasculitis. Clin Exp Immunol 1995; 101: 213–9
   PubMedGoogle Scholar
• Silveira AMV, Yamamoto T, Adamson L, Hessel B, Blomback B. Application of an enzyme-linked immunosorbent assay to von Willebrand factor and its derivatives. Thromb Res 1986; 43: 91–102
   PubMedGoogle Scholar
• Lefvert AK. Recurrent angioedema caused by circulating immune complexes containing antibodies against bovine proteins. Int Arch Allergy Immunol 1993; 102: 112–6
   PubMedGoogle Scholar
• Juto P, Holm S. Gliadin-specific and cow's milk protein-specific IgA in human milk. J Pediatr Gastr Nutr 1992; 15: 159–62
   PubMedGoogle Scholar
• Arfors L, Lefvert AK. Enrichment of antibodies against phospholipids in circulating immune complexes (CIC) in the anti-phospholipid syndrome (APLS). Clin Exp Immunol 1997; 108: 47–51
   PubMedGoogle Scholar
• Lowry H, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. Biol Chem 1951; 193: 265–75
   Web of Science ®Google Scholar
• Creighton WD, Lambert PH, Miescher PA. Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol. J Immunol 1973; 111: 1219–27
   PubMed Web of Science ®Google Scholar
• Nityanand S, Dawkins R, Holm G, Lithell H, Lefvert AK. C4Q0 alleles in a Swedish population. Eur J Immunogenet 1995; 22: 435–41
   PubMedGoogle Scholar
• Carlson K. Lipoprotein fractionation. J Clin Pathol 1973; 5: 32–7
   Google Scholar
• Vermylen C, de Vreker RA, Verstraete M. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time test. Clin Chim Acta 1963; 8: 418–24
   PubMed Web of Science ®Google Scholar
• Walker WA, Isselbacher KJ. Uptake and transport of macromolecules by the intestine. Possible role in clinical disorders. Gastroenterology 1974; 67: 531–50
   PubMed Web of Science ®Google Scholar
• Peterson RD, Good RA. Antibodies to cow's milk proteins-their presence and significance. Pediatrics 1963; 31: 209–21
   PubMedGoogle Scholar
• Paganelli RD, Levinsky RJ. Solid phase radioimmunoassay for detection of circulating food protein antigens in human serum. J Immunol Methods 1980; 37: 333–41
   PubMed Web of Science ®Google Scholar
• May CD, Remingio L, Feldman J, Bock SA, Carr RI. A study of serum antibodies to isolated milk proteins and ovalbumin in infants and children. Clin Allergy 1977; 7: 583–9
   PubMedGoogle Scholar
• Brostoff J, Carini C, Wraith DG, Paganelli R, Levinsky RJ. Immune complexes in atopy. The mast cell, J Pepys, AM Edwards. Pitman, LondonUK 1979; 380–93
   Google Scholar
• Levinsky RJ, Paganelli R, Roberton DM, Atherton DJ. Handling of food antigens and their complexes by normal and allergic individuals. The antigens, Wilkinson AW. Plenum Press, New York, NY 1981; 23–31
   Google Scholar
• Elson CO, Heck JA, Strober W. T cell regulation of murine IgA synthesis. J Exp Med 1979; 127: 632–9
   Google Scholar
• Heremans JF. The IgA system in connection with local and systemic immunity. Adv Exp Med Biol 1974; 45: 3–11
   PubMedGoogle Scholar
• Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956–63
   PubMed Web of Science ®Google Scholar
• Torzewski M, Torzewski J, Bowyer DE, Waltenberger J, Fitzsimmons C, Hombach V. Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions. Arterioscler Throm Vase Biol 1997; 17: 2448–52
   PubMed Web of Science ®Google Scholar
• Torzewski J, Bowyer DE, Waltenberger J, Fitzsimmons C. Processes in atherogenesis: complement activation. Atherosclerosis 1997; 132: 131–8
   PubMed Web of Science ®Google Scholar
• Hauptmann G. Inherited deficiency of the fourth component of human complement. Immunol Rev 1988; 1: 3–22
   Google Scholar
• Cameron U, Cobain TJ, Zhang WJ, Kay PH, Dawkins RL. Influence of C4 null genes on infection with human immunodeficiency virus. BMJ 1988; 296: 1627–8
   PubMedGoogle Scholar
• Bishof NA, Welch TR, Beischel LS. C4B deficiency: a risk factor for bacteremia with encapsulated organisms. J Infect Dis 1990; 162: 248–50
   PubMed Web of Science ®Google Scholar
• Kramer J, Rajczy K, Hegyi L, Fülöp T, Mohacsi A, Mezei Z. C4Bast;Q0 allotype as risk factor for myocardial infarction. BMJ 1994; 309: 313–4
   PubMed Web of Science ®Google Scholar
• Kramer J, Rajezy K, Füst G. Low incidence of null alleles of the fourth component of complement (C4) in elderly people. Immunol Lett 1989; 20: 83–6
   PubMedGoogle Scholar
• Kramer J, Fülöp T, Rajczy K, Anh-Tuan N, Fiist G. A marked drop in the incidence of the null allele of the B gene of the fourth component of complement (C4Bast;Q0) in elderly subjects: C4Bast;Q0 as a probably negative selection factor for survival. Hum Genet 1991; 86: 595–8
   PubMed Web of Science ®Google Scholar
• Nityanand S, Hamsten A, Lithell H, Holm G, Lefvert AK. C4 null alleles and myocardial infarction. Atherosclerosis 1999; 43: 377–81
   Google Scholar
• Lollar P. The association of factor VIII with von Willebrand factor. Mayo Clin Proc 1991; 66: 524–34
   PubMedGoogle Scholar
• Fuster V, Lie JT, Badimon L, Rosemark JA, Badimon JJ, Bowie EJ. Spontaneous and diet-induced coronary atherosclerosis in normal swine and swine with von Willebrand disease. Atherosclerosis 1985; 5: 67–73
   Google Scholar
• Hamsten A, Blombäck M, Wiman B. Haemostatic function in myocardial infarction. Br Heart J 1986; 55: 58–66
   PubMedGoogle Scholar
• Haines AP, Howarth D, North WRS. Haemostatic variables and the outcome of myocardial infarction. Thromb Haemost 1983; 50: 800–3
   PubMedGoogle Scholar
• Thompson SG, Kienast J, Pyke SD, Haverkate F, von de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995; 332: 635–41
   PubMed Web of Science ®Google Scholar
• Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351–5
   PubMedGoogle Scholar
• Mannucci M. von Willebrand factor a marker of endothelial damage. Arterioscler Throm Vasc Biol 1998; 18: 1359–62
   PubMed Web of Science ®Google Scholar
• Sadler JE. von Willebrand factor. J Biol Chem 1991; 266: 22777–84
   PubMed Web of Science ®Google Scholar
• Mustafa A, Nityanand S, Berglund L, Lithell H, Lefvert AK. Circulating immune complexes in 50-year-old men is a strong and independent risk factor for myocardial infarction. Circulation 2000; 102: 2576–81
   PubMedGoogle Scholar